Media contacts


 

Meghana Sharafudeen
+41 79 711 5554
msharafudeen@gavi.org
 

Meghana Sharafudeen

Laura Shevlin
+ 41 79 529 92 87
lshevlin@gavi.org
 

Laura Shevlin

Cirũ Kariũki
+41 79 913 94 41
ckariuki@gavi.org
 

Cirũ Kariũki

Collins Weru Mwai
+250787836638
cmwai@gavi.org

Collins Weru Mwai

Eunice Kilonzo-Muraya
+41 76 424 85 03
ekilonzo@gavi.org

Eunice Kilonzo-Muraya

Latest news releases

View all releases

Measles vaccines have contributed to dramatic reduction in cases and deaths since 2000

A new report from the World Health Organization (WHO) underscores the remarkable progress made in the fight against measles over the past 24 years.

Ethiopia takes a major step to prevent mother-to-child transmission of Hepatitis B virus with birth dose vaccine introduction

Ethiopia has launched the national introduction of the HepB BD vaccine, marking a major step in strengthening newborn immunization and combating the transmission of Hepatitis B virus. 

Gavi and UNICEF announce equitable pricing deal for malaria vaccine to protect 7 million more children by end of decade

Deal secures more accessible future price per dose, resulting savings of up to US$ 90 million. Savings expected to help secure 30 million additional doses, protecting up to 7 million more children with malaria vaccine.

Media resources | assets

If you would you like to receive updates from the Gavi media team, or request access to our digital library of high-resolution images and B-roll, please email media@gavi.org.

Facts and figures

GAVI/2017/Guido Dingemans/Mozambique

Gavi progress reports

Credit: Gavi/2013/Evelyn Hockstein

Types of support

Gavi/2017/Juliette Bastin/Burkina Faso

Communication toolkits

Gavi/2024/Jjumba Martin

Country hub

Gavi/2014/GMB Akash

Snap analyses

Gavi/2022/Benedikt v.Loebell

Gavi leadership

José Manuel Barroso
Board Chair

José Manuel Barroso

Dr Sania Nishtar
CEO

Dr Sania Nishtar

Gavi Secretariat
 

Gavi/2025

Opinions

View all opinions

New vaccines could help us consign tuberculosis to history: here’s how we can do it

New tuberculosis vaccine candidates are currently going through the final stages of clinical trials. We need to work together to ensure they reach the millions who need them quickly and effectively.

Three years ago we made a promise to girls around the world to help end the scourge of cervical cancer. Today we have honoured it.

In December 2022 Gavi set an ambitious target of reaching 86 million girls with the HPV vaccine by the end of 2025. We have met it ahead of schedule.

Gavi is leaping into the future: there is no time to lose

Gavi CEO Dr Sania Nishtar introduces the Gavi Leap, transforming the Vaccine Alliance for the future through simplicity, transparency and synergy.

Last updated: 7 May 2025